Angewandte Chemie International Edition · 2015 · 93 citations · 43 references
PharmacyChemical BiologyMedicinal ChemistryDrug DesignDrug DiscoveryProtein-protein InteractionsEnzyme InhibitionLigand BindingProtein StructureProtein-ligand BindingProtein-ligand InteractionsProtein-protein Interaction ModulationAlpha-helix MimicsHelical AssemblyLigand Binding SelectivityProtein Binding SelectivityProtein-protein Interaction Inhibitor DesignProtein-protein Interaction Inhibitor DiscoveryStructure-based PeptidomimeticsTarget-ligand Interactions
Inhibition of protein-protein interactions (PPIs) represents a major challenge in chemical biology and drug discovery. α-Helix mediated PPIs may be amenable to modulation using generic chemotypes, termed "proteomimetics", which can be assembled in a modular manner to reproduce the vectoral presentation of key side chains found on a helical motif from one partner within the PPI. In this work, it is demonstrated that by using a library of N-alkylated aromatic oligoamide helix mimetics, potent helix mimetics which reproduce their biophysical binding selectivity in a cellular context can be identified.
43
In Vivo Activation of the p53 Pathway by Small-Molecule Antagonists of MDM2
Lyubomir T. Vassilev, Binh Thanh Vu, Bradford Graves et al. · Science · 2004 · 4.7K citations
Medicine, Oncology, Pharmacology +15
Estimating the size of the human interactome
Michael P. H. Stumpf, Thomas Thorne, Eric de Silva et al. · Proceedings of the National Academy of Sciences · 2008 · 824 citations · Full text
Gilles Guichard, Ivan Huc · Chemical Communications · 2011 · 746 citations